BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22532293)

  • 1. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.
    Azuara D; Rodriguez-Moranta F; de Oca J; Sanjuan X; Guardiola J; Lobaton T; Wang A; Boadas J; Piqueras M; Monfort D; Galter S; Esteller M; Moreno V; Capellá G
    Inflamm Bowel Dis; 2013 Jan; 19(1):165-73. PubMed ID: 22532293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
    Azuara D; Aussó S; Rodriguez-Moranta F; Guardiola J; Sanjuan X; Lobaton T; Boadas J; Piqueras M; Monfort D; Guinó E; Moreno V; Capellá G; de Oca J
    Inflamm Bowel Dis; 2018 Nov; 24(12):2555-2564. PubMed ID: 30099509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance.
    Johnson DH; Taylor WR; Aboelsoud MM; Foote PH; Yab TC; Cao X; Smyrk TC; Loftus EV; Mahoney DW; Ahlquist DA; Kisiel JB
    Inflamm Bowel Dis; 2016 Jul; 22(7):1559-67. PubMed ID: 27104828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between methylation and colonic inflammation in inflammatory bowel disease.
    Lobatón T; Azuara D; Rodríguez-Moranta F; Loayza C; Sanjuan X; de Oca J; Fernández-Robles A; Guardiola J; Capellá G
    World J Gastroenterol; 2014 Aug; 20(30):10591-8. PubMed ID: 25132780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.
    Robles AI; Traverso G; Zhang M; Roberts NJ; Khan MA; Joseph C; Lauwers GY; Selaru FM; Popoli M; Pittman ME; Ke X; Hruban RH; Meltzer SJ; Kinzler KW; Vogelstein B; Harris CC; Papadopoulos N
    Gastroenterology; 2016 Apr; 150(4):931-43. PubMed ID: 26764183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia.
    Papadia C; Louwagie J; Del Rio P; Grooteclaes M; Coruzzi A; Montana C; Novelli M; Bordi C; de' Angelis GL; Bassett P; Bigley J; Warren B; Atkin W; Forbes A
    Inflamm Bowel Dis; 2014 Feb; 20(2):271-7. PubMed ID: 24280874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.
    Carmona FJ; Azuara D; Berenguer-Llergo A; Fernández AF; Biondo S; de Oca J; Rodriguez-Moranta F; Salazar R; Villanueva A; Fraga MF; Guardiola J; Capellá G; Esteller M; Moreno V
    Cancer Prev Res (Phila); 2013 Jul; 6(7):656-65. PubMed ID: 23694962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High-Grade Dysplasia in Patients With Inflammatory Bowel Disease.
    Kisiel JB; Klepp P; Allawi HT; Taylor WR; Giakoumopoulos M; Sander T; Yab TC; Moum BA; Lidgard GP; Brackmann S; Mahoney DW; Roseth A; Ahlquist DA
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):914-921.e5. PubMed ID: 29775793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
    Zheng HH; Jiang XL
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.
    Garrity-Park MM; Loftus EV; Bryant SC; Smyrk TC
    Inflamm Bowel Dis; 2016 Jul; 22(7):1568-74. PubMed ID: 27135485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.
    Kisiel JB; Garrity-Park MM; Taylor WR; Smyrk TC; Ahlquist DA
    Inflamm Bowel Dis; 2013 Sep; 19(10):2079-83. PubMed ID: 23867875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular alterations in colitis-associated colorectal neoplasia: study from a low prevalence area using magnifying chromo colonoscopy.
    Shivakumar BM; Kumar BL; Bhat G; Suvarna D; Rao L; Pai CG; Satyamoorthy K
    J Crohns Colitis; 2012 Jul; 6(6):647-54. PubMed ID: 22398042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
    Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
    Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.
    Kisiel JB; Yab TC; Nazer Hussain FT; Taylor WR; Garrity-Park MM; Sandborn WJ; Loftus EV; Wolff BG; Smyrk TC; Itzkowitz SH; Rubin DT; Zou H; Mahoney DW; Ahlquist DA
    Aliment Pharmacol Ther; 2013 Mar; 37(5):546-54. PubMed ID: 23347191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis.
    Kim TO; Park J; Kang MJ; Lee SH; Jee SR; Ryu DY; Yang K; Yi JM
    Int J Mol Med; 2013 May; 31(5):1255-61. PubMed ID: 23546389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer in inflammatory bowel disease: review of the evidence.
    Keller DS; Windsor A; Cohen R; Chand M
    Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.